Trial intelligence / Profile preview

Pharmacokinetics of single-dose immediate- and extended-release methylphenidate in healthy volunteers

2010-020014-28Phase 4Completed

Sponsor
Centre for Human Drug Research
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Saliva methylphenidate concentrations and Plasma methylphenidate concentrations. Started Apr 2010; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2010-020014-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020014-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call